- Home
- EPSN vs ACHV Comparison
EPSN vs ACHV Comparison
Compare EPSN & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPSN
- ACHV
- Stock Information
- Founded
- EPSN 2005
- ACHV N/A
- Country
- EPSN Canada
- ACHV Canada
- Employees
- EPSN N/A
- ACHV N/A
- Industry
- EPSN Oil & Gas Production
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- EPSN Energy
- ACHV Health Care
- Exchange
- EPSN Nasdaq
- ACHV Nasdaq
- Market Cap
- EPSN 142.3M
- ACHV 126.9M
- IPO Year
- EPSN N/A
- ACHV N/A
- Fundamental
- Price
- EPSN $6.21
- ACHV $3.17
- Analyst Decision
- EPSN Strong Buy
- ACHV Strong Buy
- Analyst Count
- EPSN 1
- ACHV 5
- Target Price
- EPSN $7.00
- ACHV $14.80
- AVG Volume (30 Days)
- EPSN 33.5K
- ACHV 229.0K
- Earning Date
- EPSN 03-19-2025
- ACHV 03-27-2025
- Dividend Yield
- EPSN 4.03%
- ACHV N/A
- EPS Growth
- EPSN N/A
- ACHV N/A
- EPS
- EPSN 0.24
- ACHV N/A
- Revenue
- EPSN $31,145,315.00
- ACHV N/A
- Revenue This Year
- EPSN N/A
- ACHV N/A
- Revenue Next Year
- EPSN $15.65
- ACHV N/A
- P/E Ratio
- EPSN $25.85
- ACHV N/A
- Revenue Growth
- EPSN N/A
- ACHV N/A
- 52 Week Low
- EPSN $4.90
- ACHV $2.84
- 52 Week High
- EPSN $6.75
- ACHV $5.59
- Technical
- Relative Strength Index (RSI)
- EPSN 48.82
- ACHV 44.06
- Support Level
- EPSN $5.93
- ACHV $3.18
- Resistance Level
- EPSN $6.59
- ACHV $3.59
- Average True Range (ATR)
- EPSN 0.22
- ACHV 0.21
- MACD
- EPSN 0.02
- ACHV 0.01
- Stochastic Oscillator
- EPSN 51.28
- ACHV 19.48
About EPSN Epsilon Energy Ltd. Common Share
Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.